Healthcare • Drug Manufacturers - Specialty & Generic
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BHC is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
38 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 56 days ago
Red flags: 0
218 filers reported a long position in BHC for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| PAULSON & CO. INC. | $361.2M | 73.3M | Unchanged |
| GOLDENTREE ASSET MANAGEMENT LP | $170.7M | 34.7M | Unchanged |
| ROYAL BANK OF CANADA | $53.4M | 10.8M | -4.7% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $39.4M | 8M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $36.8M | 7.5M | +0.8% |
| GEODE CAPITAL MANAGEMENT, LLC | $33.2M | 4.8M | +13.6% |
| GOLDMAN SACHS GROUP INC | $30.7M | 6.2M | +19.5% |
| MFN Partners Management, LP | $29.6M | 6M | Unchanged |
| SG Americas Securities, LLC | $27.3M | 5.5M | +37,278.6% |
| ACADIAN ASSET MANAGEMENT LLC | $27M | 5.5M | +12.4% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.